BIRB-796, 1 mg

BIRB-796 is a small molecule research tool supplied by STEMCELL Technologies. According to the manufacturer, it acts as a highly potent inhibitor of p38 MAPK and blocks TNFa release in LPS-stimulated THP-1 cells. It is listed in the company's small molecules for stem cell research product line, where it is categorized as a p38 MAPK inhibitor used in maintenance workflows.

As part of STEMCELL Technologies' small molecule portfolio, the compound is described as cell permeable and able to affect intracellular signaling pathways. Small molecules in this range are positioned as more stable and cost effective than growth factors, and as chemically defined with high purity and low lot-to-lot variability in activity, allowing researchers to fine-tune effects by varying concentration.

The product is intended for research use only and is not for human or animal diagnostic or therapeutic uses unless otherwise stated.